106 related articles for article (PubMed ID: 22484044)
21. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
[TBL] [Abstract][Full Text] [Related]
22. The behavior of PLGA microspheres containing rifampicin in alveolar macrophages.
Onoshita T; Shimizu Y; Yamaya N; Miyazaki M; Yokoyama M; Fujiwara N; Nakajima T; Makino K; Terada H; Haga M
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):151-7. PubMed ID: 19954935
[TBL] [Abstract][Full Text] [Related]
23. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
Díez S; Tros de Ilarduya C
Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
[TBL] [Abstract][Full Text] [Related]
24. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
25. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone.
Kim HK; Chung HJ; Park TG
J Control Release; 2006 May; 112(2):167-74. PubMed ID: 16542746
[TBL] [Abstract][Full Text] [Related]
26. Protein complexed with chondroitin sulfate in poly(lactide-co-glycolide) microspheres.
Lee ES; Park KH; Kang D; Park IS; Min HY; Lee DH; Kim S; Kim JH; Na K
Biomaterials; 2007 Jun; 28(17):2754-62. PubMed ID: 17337049
[TBL] [Abstract][Full Text] [Related]
27. Mapping neutral microclimate pH in PLGA microspheres.
Li L; Schwendeman SP
J Control Release; 2005 Jan; 101(1-3):163-73. PubMed ID: 15588902
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of localized immunosuppression: 2. PLA microspheres for the sustained local delivery of a soft immunosuppressant.
Pinto E; Zhang B; Song S; Bodor N; Buchwald P; Hochhaus G
Pharmazie; 2010 Jun; 65(6):429-35. PubMed ID: 20614691
[TBL] [Abstract][Full Text] [Related]
29. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite.
Ho ML; Fu YC; Wang GJ; Chen HT; Chang JK; Tsai TH; Wang CK
J Control Release; 2008 Jun; 128(2):142-8. PubMed ID: 18436324
[TBL] [Abstract][Full Text] [Related]
30. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures.
Virto MR; Elorza B; Torrado S; Elorza Mde L; Frutos G
Biomaterials; 2007 Feb; 28(5):877-85. PubMed ID: 17064761
[TBL] [Abstract][Full Text] [Related]
31. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
[TBL] [Abstract][Full Text] [Related]
32. Retinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure.
Checa-Casalengua P; Jiang C; Bravo-Osuna I; Tucker BA; Molina-Martínez IT; Young MJ; Herrero-Vanrell R
J Control Release; 2011 Nov; 156(1):92-100. PubMed ID: 21704662
[TBL] [Abstract][Full Text] [Related]
33. Microencapsulation of inorganic nanocrystals into PLGA microsphere vaccines enables their intracellular localization in dendritic cells by electron and fluorescence microscopy.
Schliehe C; Schliehe C; Thiry M; Tromsdorf UI; Hentschel J; Weller H; Groettrup M
J Control Release; 2011 May; 151(3):278-85. PubMed ID: 21223984
[TBL] [Abstract][Full Text] [Related]
34. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
[TBL] [Abstract][Full Text] [Related]
35. Healing kinetics of microneedle-formed pores in PLGA films.
Mazzara JM; Balagna MA; Thouless MD; Schwendeman SP
J Control Release; 2013 Oct; 171(2):172-7. PubMed ID: 23831588
[TBL] [Abstract][Full Text] [Related]
36. Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system.
Choi DH; Park CH; Kim IH; Chun HJ; Park K; Han DK
J Control Release; 2010 Oct; 147(2):193-201. PubMed ID: 20647022
[TBL] [Abstract][Full Text] [Related]
37. Improvement of survival in C6 rat glioma model by a sustained drug release from localized PLGA microspheres in a thermoreversible hydrogel.
Ozeki T; Kaneko D; Hashizawa K; Imai Y; Tagami T; Okada H
Int J Pharm; 2012 May; 427(2):299-304. PubMed ID: 22366485
[TBL] [Abstract][Full Text] [Related]
38. A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres.
Zheng CH; Gao JQ; Zhang YP; Liang WQ
Biochem Biophys Res Commun; 2004 Oct; 323(4):1321-7. PubMed ID: 15451441
[TBL] [Abstract][Full Text] [Related]
39. Interaction of recombinant human bone morphogenetic protein-2 with poly(d,l lactide-co-glycolide) microspheres.
Duggirala SS; Mehta RC; DeLuca PP
Pharm Dev Technol; 1996 Apr; 1(1):11-9. PubMed ID: 9552326
[TBL] [Abstract][Full Text] [Related]
40. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer.
He J; Feng M; Zhou X; Ma S; Jiang Y; Wang Y; Zhang H
Int J Pharm; 2011 Sep; 416(1):69-76. PubMed ID: 21699969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]